InvestorsHub Logo
Followers 135
Posts 21967
Boards Moderated 2
Alias Born 04/17/2006

Re: None

Tuesday, 05/26/2015 9:07:55 AM

Tuesday, May 26, 2015 9:07:55 AM

Post# of 51
news out

FDA Grants IND to Critical Outcome Technologies for COTI-2, the Company's Activator of Mutant p53 Protein
Company Finalizing Plans to Commence Clinical Trial for COTI-2 in the Second Half of 2015


http://www.marketwired.com/press-release/-2023097.htm

$COTQF ~ $COT.V

YOU SHOULD NOT MAKE ANY DECISION, FINANCIAL, INVESTMENTS, TRADING OR OTHERWISE, BASED ON ANY OF THE INFORMATION PRESENTED IN THIS MESSAGE WITHOUT UNDERTAKING INDEPENDENT DUE DILIGENCE AND CONSULTATION WITH A PROFESSIONAL BROKER OR FINANCIAL ADVISOR.